Browse our anti-PRKAB1 (PRKAB1) Antibodies

Human Protein Kinase, AMP-Activated, beta 1 Non-Catalytic Subunit (PRKAB1) interaction partners

1. Salicylate activates the AMP-activated protein kinase (AMPK (show PRKAA2 Antibodies)) by binding at the A-769662 drug binding site on the AMPK (show PRKAA1 Antibodies) beta1-subunit

2. findings suggest that the reduced expression of AMPK (show PRKAA1 Antibodies)-beta1 confers lower AMPK (show PRKAA1 Antibodies) activity, which enhances the oncogenic capacity of advanced-stage ovarian cancer.

3. The effects of ethanol on AMPK (show PRKAA1 Antibodies) and PP2A (show PPP2R4 Antibodies) may result in activation of ChREBP (show MLXIPL Antibodies), providing another potential mechanism for ethanol-induced hepatic steatosis.

4. Data indicate that a diet high in iron improves glucose tolerance by activating AMPK (show PRKAA1 Antibodies) through mechanisms that include deacetylation.

5. LKB1 (show STK11 Antibodies) controls IRS1 (show IRS1 Antibodies)-dependent adipogenesis via AMPK (show PRKAA1 Antibodies) in white adipose tissue.

6. Data indicate that except AMPK (show PRKAA1 Antibodies)-alpha1, expressions of the other five AMPK (show PRKAA1 Antibodies) subunits -alpha2, -beta1, -beta2, -gamma1 and -gamma2 are significantly higher in ovarian carcinomas.

7. Changes in translational control of mitochondrial proteins are signaled by the activation of AMPK and general control non-derepressible kinase 2 (GCN2), leading also to the activation of autophagy.

8. Phosphorylation levels of AMPK (show PRKAA1 Antibodies) and glycolysis were up-regulated to confer an advantage of survival for MERRF skin fibroblasts.

9. Adipose tissues of markedly obese insulin (show INS Antibodies) resistant individuals uniformly show decreased AMPK (show PRKAA1 Antibodies) activity and increased oxidative stress compared with insulin (show INS Antibodies) sensitive patients.

10. In breast cancer cells SESN2 (show SESN2 Antibodies) is associated with AMPK (show PRKAA1 Antibodies).

Mouse (Murine) Protein Kinase, AMP-Activated, beta 1 Non-Catalytic Subunit (PRKAB1) interaction partners

1. In lipid-laden macrophages, Ampk (show PRKAA1 Antibodies) activation decreased cholesterol content (foam cell formation) and increased cholesterol efflux to HDL (show HSD11B1 Antibodies) and apoA-I (show APOA1 Antibodies), effects that occurred in an Ampk (show PRKAA1 Antibodies) beta1-dependent manner.

2. Salicylate activates the AMP-activated protein kinase (AMPK (show PRKAA2 Antibodies)) by binding at the A-769662 drug binding site on the AMPK (show PRKAA1 Antibodies) beta1-subunit

3. AMPK (show PRKAA1 Antibodies) directly relaxes vascular smooth muscle cell by a decrease of [Ca(2 (show CA2 Antibodies)+)]i. This is achieved by calcium sequestration via SERCA (show ATP2A3 Antibodies) activation, as well as activation of BKCa (show KCNMA1 Antibodies) channels.

4. Norepinephrine increases the expression of PGC-1alpha in parallel with the activation of AMPK (show PRKAA1 Antibodies) signaling in mouse epididymal adipose tissue.

5. AMPK (show PRKAA1 Antibodies) beta1beta2 have a role in preventing myopathy due to loss of capillary density in nonpostural muscles

6. PPARbeta (show PPARD Antibodies)/delta, but not PPARalpha (show PPARA Antibodies), interacts with the exercise-inducible kinase AMP-activated protein kinase (AMPK (show PRKAA2 Antibodies)) to synergistically activate Ldhb (show LDHB Antibodies) gene transcription by cooperating with myocyte enhancer factor 2A (MEF2A (show MEF2A Antibodies)) in a PPARbeta (show PPARD Antibodies)/delta ligand-independent manner

7. The aim of this study was to determine whether activation of AMPK (show PRKAA1 Antibodies) by acute renal ischemia influences the severity of renal ischemia-reperfusion injury.

8. AMPK (show PRKAA1 Antibodies) beta1 protects macrophages from inflammation under high lipid exposure from a high fat diet. beta1(-/-) macrophages displayed increased levels of diacylglycerol and markers of inflammation.

9. cisplatin-triggered activation of AMPK (show PRKAA1 Antibodies) and subsequent suppression of mTOR (show FRAP1 Antibodies) activity can induce an autophagic response that protects tumour cells from cisplatin-mediated apoptotic death

10. Phosphorylation of AMPK (show PRKAA1 Antibodies) by Ulk1 (show ULK1 Antibodies) represents a negative feedback circuit.

Cow (Bovine) Protein Kinase, AMP-Activated, beta 1 Non-Catalytic Subunit (PRKAB1) interaction partners

1. The extent of genetic polymorphisms in the promoter region of PRKAB1 gene was investigated in a sample of 811 Chinese indigenous bovine individuals.

2. Sequence analysis of 811 Chinese indigenous bovine individuals revealed 29 single nucleotide polymorphisms (SNPs) of bovine PRKAB1 gene.